Related Experiment Videos
Immune mechanism in Pasteurella multocida-infected mice
Infection and Immunity
|March 1, 1976
Summary
Different immunization methods were evaluated for Pasteurella multocida (P. multocida) growth control in mice. Killed vaccines with Freund complete adjuvant offered strong protection, especially against parenteral challenges, highlighting adjuvant benefits for P. multocida immunity.
Area of Science:
- Veterinary Immunology
- Bacteriology
- Infectious Disease
Background:
- Pasteurella multocida (P. multocida) is a significant pathogen in animal health.
- Effective immunization strategies are crucial for controlling P. multocida infections.
- Understanding immune responses to P. multocida is vital for vaccine development.
Purpose of the Study:
- To evaluate various immunizing procedures against Pasteurella multocida in mice.
- To compare the efficacy of adjuvant-adjuvanted vaccines versus non-adjuvanted vaccines.
- To assess the protective potential of hyperimmune serum against P. multocida challenge.
Main Methods:
- Testing killed P. multocida vaccines with and without Freund complete adjuvant.
- Aerogenic administration of vaccines and challenge inoculums.
- Immunopotentiation of killed vaccine using live Mycobacterium bovis (BCG).
- Passive immunization using hyperimmune mouse serum administered via different routes.
Main Results:
- Adjuvant-treated killed vaccines provided superior protection against parenteral challenge compared to non-adjuvant vaccines.
- Aerogenic vaccine administration showed marginal resistance increase against small challenges.
- Live BCG vaccine enhanced the immune response to a single dose of killed P. multocida vaccine.
- Hyperimmune mouse serum conferred high protection against subcutaneous challenge, with localized inflammatory responses observed.
Conclusions:
- Freund complete adjuvant significantly enhances protection against P. multocida, particularly for parenteral routes.
- Passive immunity via hyperimmune serum is highly effective but can induce local reactions.
- Further research into optimal vaccine formulations and delivery methods for P. multocida is warranted.